| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Conversion | - | 1,000 | - | 1,000 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Sale | $9.02 | 37,210 | 335,760 | 582,805 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 15, 2022 | Tax Payment (Shares) | $11.86 | 5,751 | 68,207 | 570,265 | Nov 17, 2022, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Conversion | - | 1,000 | - | 1,000 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,098 | 0 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,099 | 0 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Conversion | - | 500 | - | 500 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Conversion | - | 18,500 | - | 594,516 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Sale | $10.11 | 500 | 5,055 | 0 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 594,209 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Conversion | - | 1,000 | - | 1,000 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 03, 2022 | Sale | $10.00 | 36,693 | 366,947 | 576,016 | Nov 04, 2022, 06:39 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 580,512 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Conversion | - | 1,000 | - | 1,000 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Sale | $11.58 | 36,053 | 417,468 | 562,959 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,643 | 0 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Conversion | - | 1,000 | - | 1,000 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,641 | 0 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Conversion | - | 500 | - | 500 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Conversion | - | 18,500 | - | 581,459 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 500 | 5,821 | 0 | Oct 07, 2022, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Conversion | - | 500 | - | 500 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Conversion | - | 18,500 | - | 567,762 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 500 | 5,249 | 0 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 567,328 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Conversion | - | 1,000 | - | 1,000 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Sale | $10.34 | 36,566 | 377,944 | 549,262 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,502 | 0 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Conversion | - | 1,000 | - | 1,000 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,504 | 0 | Sep 02, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 15, 2022 | Tax Payment (Shares) | $12.96 | 5,751 | 74,533 | 536,078 | Aug 17, 2022, 06:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,447 | 0 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Conversion | - | 500 | - | 500 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Conversion | - | 18,500 | - | 560,329 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Sale | $9.44 | 500 | 4,722 | 0 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 560,154 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Conversion | - | 1,000 | - | 1,000 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Sale | $9.49 | 36,825 | 349,441 | 541,829 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,448 | 0 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 04, 2022 | Conversion | - | 1,000 | - | 1,000 | Aug 05, 2022, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,070 | 0 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Conversion | - | 1,000 | - | 1,000 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Sale | $9.07 | 1,000 | 9,068 | 0 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Conversion | - | 500 | - | 500 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Conversion | - | 18,500 | - | 547,404 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Sale | $9.06 | 500 | 4,531 | 0 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 547,518 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Conversion | - | 1,000 | - | 1,000 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 07, 2022 | Sale | $9.05 | 37,114 | 335,978 | 528,904 | Jul 08, 2022, 06:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 500 | 3,172 | 0 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Sale | $6.09 | 39,690 | 241,766 | 516,268 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Conversion | - | 1,000 | - | 1,000 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Conversion | - | 1,000 | - | 1,000 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Sale | $6.35 | 1,000 | 6,346 | 0 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Sale | $6.34 | 1,000 | 6,341 | 0 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Conversion | - | 18,500 | - | 534,768 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Conversion | - | 500 | - | 500 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 02, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 537,458 | Jun 06, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 16, 2022 | Tax Payment (Shares) | $5.67 | 5,764 | 32,682 | 506,208 | May 18, 2022, 07:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 500 | 3,221 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Conversion | - | 18,500 | - | 530,472 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 1,000 | 6,474 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Conversion | - | 1,000 | - | 1,000 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 18,500 | 119,118 | 511,972 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Conversion | - | 500 | - | 500 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Sale | $6.43 | 1,000 | 6,435 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Conversion | - | 18,500 | - | 530,472 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Conversion | - | 1,000 | - | 1,000 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Sale | $6.47 | 500 | 3,235 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 525,302 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Sale | $6.44 | 1,000 | 6,439 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Conversion | - | 1,000 | - | 1,000 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Sale | $6.49 | 31,830 | 206,497 | 511,972 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 05, 2022 | Conversion | - | 500 | - | 500 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Sale | $6.48 | 1,000 | 6,481 | 0 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 04, 2022 | Conversion | - | 1,000 | - | 1,000 | May 06, 2022, 08:13 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Conversion | - | 18,500 | - | 488,108 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Conversion | - | 1,000 | - | 1,000 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Sale | $6.18 | 38,070 | 235,333 | 494,052 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Sale | $6.05 | 500 | 3,026 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 488,713 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Sale | $6.30 | 1,000 | 6,304 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Conversion | - | 1,000 | - | 1,000 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Conversion | - | 1,000 | - | 1,000 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Sale | $6.09 | 37,605 | 229,116 | 469,608 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Sale | $6.31 | 1,000 | 6,307 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Sale | $6.07 | 1,000 | 6,069 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Conversion | - | 1,000 | - | 1,000 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Conversion | - | 500 | - | 500 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Conversion | - | 18,500 | - | 512,552 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Sale | $6.07 | 1,000 | 6,070 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Sale | $6.31 | 500 | 3,156 | 0 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 29, 2022 | Option/RSU Exercise | $2.48 | 44,014 | 109,155 | 513,622 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 28, 2022 | Conversion | - | 500 | - | 500 | May 02, 2022, 09:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 464,156 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Sale | $5.99 | 500 | 2,995 | 0 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Conversion | - | 500 | - | 500 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Conversion | - | 18,500 | - | 438,646 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Sale | $6.04 | 37,953 | 229,175 | 444,703 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 25, 2022, 09:26 PM |
